Associated Papers
KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
European Journal of Endocrinology, 2024
Genetic screening of hypertensive patients with aldosterone hypersecretion under conditions of stress.
Mourtzi N et al.
Hormones (athens, Greece), 2022
Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning.
Coyote-Maestas W et al.
Elife, 2022
35639599 (PubMed )
Supplement: elife-76903-data1.zip › SourceData › input_data › KCNJ_Gnomad_0325322.xlsx › Sheet1
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS et al.
Frontiers in Endocrinology, 2022
Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N et al.
Reviews in Endocrine & Metabolic Disorders, 2019
Familial hyperaldosteronism type III.
Monticone S et al.
Journal of Human Hypertension, 2017
Of channels and pumps: different ways to boost the aldosterone?
Bandulik S
Acta Physiologica (oxford, England), 2017
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A et al.
Clinical Endocrinology, 2016
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Primary Aldosteronism: Seismic Shifts.
Funder JW
The Journal of Clinical Endocrinology and Metabolism, 2015
Select a paper to view details